Real-time Stock quotes, portfolio, LIVE TV and more.
|
Jan 05, 2011, 09.41 AM IST
Natco Pharma has sought a voluntary licence from Pfizer to make and sell copies of US company's HIV drug in India, reports The Economic Times. It touched an intraday high of Rs 349 and an intraday low of Rs 323. At 09:33 hrs the share was quoting at Rs 327.95, up Rs 8.70, or 2.73% on the NSE.
Natco Pharma touched an intraday high of Rs 349 and an intraday low of Rs 323. At 09:33 hrs the share was quoting at Rs 327.95, up Rs 8.70, or 2.73% on the NSE.
The company has sought a voluntary licence from Pfizer to make and sell copies of US company's HIV drug in India, reports The Economic Times.
Related News Set email alert for Tags: Natco Pharma, Pfizer
|
Action in Natco Pharma
News Videos
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||